
GlaxoSmithKline settles fraud case for $3 billion
July 3, 2012 5:21 AM
British drug-maker GlaxoSmithKline settled a federal fraud case by agreeing to pay $3 billion in fines, and pleading guilty to criminal charges over how it sold medications. Bob Orr reports.








